Unknown

Dataset Information

0

Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas.


ABSTRACT: Claudin (CLDN)-4 expression has been associated with malignancy in various cancers. When CLDN4 expression was examined in oral squamous cell carcinoma (OSCC), 22 out of 57 (39%) cases showed immunoreactivity in the nucleus. Nuclear CLDN4-positive cases showed a stronger correlation with cancer progression than the negative cases. Intratumoral anaerobic bacterial DNA examination revealed nuclear CLDN4 expression in 81% of Clostridium perfringens-positive cases. Treatment of human oral squamous cell carcinoma cell lines HSC3 and HSC4 with Clostridium perfringens enterotoxin (CPE), induced CLDN4 nuclear translocation to enhance epithelial-mesenchymal transition (EMT), stemness, cell proliferation and invasive ability. In addition, CPE treatment suppressed phosphorylation of yes-associated protein-1 (YAP1) and promoted YAP1 nuclear translocation, resulting in increased expression of YAP1 target genes; cyclin D1 and connective tissue growth factor. Moreover, it was revealed that the complex of YAP1, CLDN4 and zona occludens-2 (ZO-2) was formed by CPE treatment, further suppressing YAP1 phosphorylation by LATS1 and activating it. Thus YAP activation in OSCC was regarded important in promoting malignant phenotypes. Our research suggested that the control of oral anaerobic bacteria may suppress YAP activation and in turn tumor progression.

SUBMITTER: Nakashima C 

PROVIDER: S-EPMC6996904 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Claudin (CLDN)-4 expression has been associated with malignancy in various cancers. When CLDN4 expression was examined in oral squamous cell carcinoma (OSCC), 22 out of 57 (39%) cases showed immunoreactivity in the nucleus. Nuclear CLDN4-positive cases showed a stronger correlation with cancer progression than the negative cases. Intratumoral anaerobic bacterial DNA examination revealed nuclear CLDN4 expression in 81% of <i>Clostridium perfringens</i>-positive cases. Treatment of human oral squa  ...[more]

Similar Datasets

| S-EPMC6998413 | biostudies-literature
| S-EPMC5520197 | biostudies-literature
| S-EPMC2707212 | biostudies-literature
| S-EPMC6801472 | biostudies-literature
| S-EPMC8909277 | biostudies-literature
| S-EPMC9463536 | biostudies-literature
| S-EPMC8431234 | biostudies-literature
| S-EPMC2798200 | biostudies-literature
| S-EPMC3153257 | biostudies-literature
| S-EPMC2804187 | biostudies-literature